PGR Progressive Corporation 10-Q 2026-09-30 section summaries
An AI model summarized each section of the report on its own; the summary was written from these. They are longer and less edited than the summary, and the filing on SEC is the authority.
Item 1, Financial Statements
Progressive (PGR) — Q3 and first nine months of 2026
Consolidated results
Amounts in $ millions except per-share data.
| Line item | Q3 2026 | Q3 2025 | 9M 2026 | 9M 2025 |
|---|---|---|---|---|
| Total revenue | $23,192 | $22,512 | $68,989 | $64,925 |
| Net premiums earned | 21,869 | 20,849 | 64,410 | 60,568 |
| Net investment income | 1,025 | 914 | 2,903 | 2,583 |
| Total expenses | 19,956 | 19,189 | 57,978 | 54,384 |
| Loss and loss adjustment expenses | 14,904 | 13,445 | 43,303 | 39,854 |
| Income before income taxes | 3,236 | 3,323 | 11,011 | 10,541 |
| Net income | 2,542 | 2,615 | 8,671 | 8,357 |
| Diluted EPS | $4.37 | $4.45 | $14.83 | $14.21 |
Q3 revenue growth slowed to 3.0% from 6.3% for the first nine months; premiums earned rose 4.9% in Q3 and 6.3% for 9M. Loss expenses grew faster than premiums—10.8% in Q3 and 8.7% for 9M—pressuring quarterly earnings. Q3 2025 expenses included a $950 million Florida policyholder credit that did not recur in 2026.
Segment underwriting results
Amounts in $ millions; quarter only.
| Segment | Q3 2026 underwriting revenue | Q3 2025 | Q3 2026 pretax underwriting profit (loss) | Q3 2025 |
|---|---|---|---|---|
| Personal Lines | $19,351 | $18,361 | $2,281 | $1,898 |
| Commercial Lines | 2,827 | 2,794 | 207 | 298 |
| Other | 2 | 0 | (15) | (6) |
| Companywide underwriting operations | 22,180 | 21,155 | 2,473 | 2,190 |
The Q3 companywide combined ratio improved to 88.7% from 89.5%. Personal Lines improved to 88.0% from 89.5%, while Commercial Lines deteriorated to 92.6% from 89.2%. Catastrophe losses rose to $388 million from $219 million. Commercial Lines underwriting profit also declined for 9M, to $888 million from $1.000 billion, as higher losses and expenses outweighed revenue trends. For 9M, the total combined ratio was 87.5% versus 87.3%; Personal Lines was 87.2% versus 87.1%, and Commercial Lines was 89.0% versus 87.8%.
Cash flow and capital returns
Amounts in $ millions; nine months ended September 30.
| Line item | 9M 2026 | 9M 2025 |
|---|---|---|
| Operating cash flow | $12,492 | $14,378 |
| Property-and-equipment purchases (capital expenditures) | 317 | 227 |
| Cash dividends paid | 8,088 | 2,812 |
| Open-market treasury-share purchases | 1,490 | 15 |
The large dividend outflow followed payment of the year-end dividend payable, which fell from $7.972 billion to $58 million. The December 2025 annual-variable dividend was $13.50 per share, approximately $7.913 billion, versus $4.50 per share and $2.637 billion in December 2024. Quarterly dividends declared during 2026 were $0.10 per share. Common shares outstanding declined from 586 million at the start of 2026 to 579 million at September 30; the comparable 2025 count was 586 million at both the start and end of 9M.
Balance sheet, investments and debt
Amounts in $ millions; balance-sheet comparison is September 30, 2026 versus December 31, 2025.
| Line item | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $127,744 | $123,039 |
| Shareholders’ equity | 34,485 | 30,323 |
| Total investments | 99,197 | 97,373 |
| Senior-note debt, carrying value | 8,389 | 6,897 |
| Loss and LAE reserves, gross | 46,786 | 43,310 |
Fixed maturities had $92.247 billion fair value against $95.719 billion amortized cost; gross unrealized losses were $3.478 billion, compared with $753 million at year-end. U.S. government securities were 41.9% of portfolio fair value, down from 44.5% at year-end and 54.3% a year earlier, as holdings shifted toward corporate and other debt and asset-backed securities. Management reported no material credit-loss allowance on fixed maturities and expected principal and interest to be paid; valuation volatility, rather than identified credit impairment, was the evident portfolio risk.
Q3 net realized securities losses were $170 million, versus $295 million of gains a year earlier; 9M gains were $314 million versus $470 million. Treasury futures used for duration management contributed $199 million of open-position holding-period losses in Q3 and $198 million for 9M. Other comprehensive loss was $1.897 billion in Q3 and $2.847 billion for 9M, principally reflecting fixed-maturity valuation changes. Accumulated other comprehensive loss was $2.744 billion after tax at September 30, 2026, versus accumulated other comprehensive income of $189 million a year earlier.
Progressive issued $1.5 billion of senior notes in March 2026—$500 million at 4.60% due 2031 and $1.0 billion at 5.15% due 2036—and received approximately $1.487 billion of net proceeds. $1.0 billion of notes due in January and March 2027 was classified as short-term debt. The $300 million PNC credit line was renewed through April 2027; there were no borrowings under it.
Reserves, taxes and risks
Gross loss and LAE reserves included $3.592 billion of reinsurance recoverables, leaving a $43.194 billion net reserve, versus $38.292 billion a year earlier. For 9M 2026, current-year incurred losses were $44.839 billion versus $40.922 billion, partly offset by more favorable prior-year development of $1.536 billion versus $1.068 billion. Favorable development included approximately $975 million from accident year 2025 and $325 million from 2024. Personal Auto contributed about $1.3 billion, primarily from lower-than-expected bodily injury severity; Commercial Lines contributed about $210 million, mainly from lower TNC injury severity, partly offset by increased severity and litigation defense costs in core commercial auto.
Effective tax rates were 21.4% for Q3 and 21.3% for 9M, versus 21.3% and 20.7%, respectively. Progressive recorded no deferred-tax-asset valuation allowance. Class and putative class actions challenge claims practices, including vehicle total-loss valuation adjustments and handling of personal injury protection and wage-loss claims. The company is contesting the cases; it considers losses reasonably possible but not probable or estimable for the multi-state vehicle-valuation suits, apart from immaterial existing accruals. An unfavorable outcome across multiple suits could materially affect financial condition, cash flows or results.
Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations
Progressive — Q3 and first nine months of 2026
Consolidated results
| $ billions, except where noted | Q3 2026 | Q3 2025 | 9M 2026 | 9M 2025 |
|---|---|---|---|---|
| Net premiums written | $22.301 | $21.384 | $67.019 | $63.666 |
| Net premiums earned | $21.869 | $20.849 | $64.410 | $60.568 |
| Underwriting profit | $2.473 | $2.190 | $8.055 | $7.715 |
| Underwriting margin | 11.3% | 10.5% | 12.5% | 12.7% |
Written premiums grew 4% in Q3 and 5% for 9M; earned premiums grew 5% and 6%, respectively. Net income decreased $73 million year over year in Q3. Total comprehensive income declined $2.254 billion, primarily because Q3 2026 had net unrealized fixed-maturity losses rather than the net unrealized gains recorded a year earlier.
Segment results
| Q3, $ millions | Net premiums earned 2026 | Net premiums earned 2025 | Underwriting profit (loss) 2026 | Underwriting profit (loss) 2025 |
|---|---|---|---|---|
| Personal Vehicles — Agency | $7,709 | $7,480 | $1,079 | $873 |
| Personal Vehicles — Direct | 10,556 | 9,819 | 986 | 737 |
| Personal Property | 795 | 790 | 216 | 288 |
| Personal Lines total | 19,060 | 18,089 | 2,281 | 1,898 |
| Commercial Lines | 2,807 | 2,760 | 207 | 298 |
| Other indemnity | 2 | 0 | (15) | (6) |
| Underwriting operations total | $21,869 | $20,849 | $2,473 | $2,190 |
Personal Lines’ Q3 underwriting margin improved to 12.0% from 10.5%; its 9M underwriting profit was $7.202 billion versus $6.729 billion. Commercial Lines’ margin fell to 7.4% from 10.8%, although 9M underwriting profit was $888 million versus $1.000 billion. Personal Lines earned premiums grew 5% in Q3 and 8% for 9M; Commercial Lines grew 2% in Q3 but declined 2% for 9M.
Growth, claims and underwriting drivers
Policies in force reached 40.489 million at September 30, up 6% year over year (38.078 million a year earlier); 2.4 million net policies were added year over year, including 0.4 million in Q3. Personal Lines had 39.237 million policies (+6%), including 11.347 million agency auto (+7%) and 16.848 million direct auto (+8%). Commercial Lines had 1.252 million (+5%). Personal Lines generated 89% of Q3 written premiums (90% a year earlier), while Commercial Lines contributed 11% (10%).
The companywide Q3 underwriting margin was above Progressive’s 4% calendar-year goal. Its 0.8-point year-over-year improvement reflected a 4.5-point lower underwriting expense ratio, largely because Q3 2025 included $950 million of Florida policyholder credits that added 4.6 points to the expense ratio. Higher losses partly offset the benefit: the loss and LAE ratio rose 3.7 points to 68.1%, primarily from severity, with higher catastrophe losses also contributing. For 9M, the combined ratio worsened 0.2 points to 87.5%, as the loss and LAE ratio increased 1.5 points to 67.2%.
Prior-accident-year reserve development was favorable by $534 million in Q3 versus $461 million, and by $1.536 billion for 9M versus $1.068 billion. The 9M benefit included $1.3 billion favorable in personal auto, primarily from lower-than-expected bodily injury severity, and about $210 million favorable in commercial auto. Higher commercial auto severity and litigation defense costs partly offset reserve benefits. Net catastrophe losses, after reinsurance and excluding LAE, were $388 million in Q3 versus $219 million, and $1.429 billion for 9M versus $1.385 billion.
Personal auto severity rose 4% in Q3 and 4% year to date, while frequency fell 3% and 2%. Commercial auto trailing-12-month severity increased 3%, while frequency declined 6%. Inflation in repair, medical and vehicle costs, litigation, weather and uncertain driving patterns remain relevant pricing and claims risks.
Personal auto policies grew, but competition weighed on retention and pricing: policy life expectancy fell 9% on both trailing three- and 12-month measures companywide. Personal auto average written premium per policy declined 2% year over year. Agency auto applications increased 8% in Q3 overall; direct auto applications grew 7%, slowing from 15% a year earlier. Personal Property applications rose 3%; homeowners new applications increased 22%, while policy life expectancy declined 7% over 12 months amid competition, prior rate increases and a mix shift toward renters. Progressive is selectively expanding property availability while managing weather exposure.
Commercial Lines written premiums rose 9% in Q3, with core commercial auto applications supported by targeted rate decreases, advertising and agent incentives. Core commercial auto retention improved, with trailing-12-month policy life expectancy up 3%. Management said pricing was adequate in most states for personal auto, personal property and core commercial auto through year-end, while continuing to monitor costs and market conditions.
Advertising was $1.6 billion in Q3 and $4.5 billion for 9M, up 18% in both periods; it added 0.8 and 0.7 points, respectively, to the expense ratio. Management intends to sustain spending while it remains efficient and consistent with profitability and acquisition-cost goals.
Investments, liquidity and capital
| Investment measure | Q3 2026 / Sep. 30, 2026 | Comparison |
|---|---|---|
| Portfolio fair value | $99.197B | $94.509B at Sep. 30, 2025; $97.373B at Dec. 31, 2025 |
| Fixed income / common equities | $94.565B / $4.632B | 95.3% / 4.7% of portfolio |
| Fixed-maturity net unrealized position, after tax | $(2.730)B | $203M gain at Sep. 30, 2025; $117M gain at Dec. 31, 2025 |
| Annualized pretax recurring book yield | 4.3% | 4.2% in Q3 2025 |
| FTE total portfolio return | (1.5)% | 1.7% in Q3 2025 |
| Fixed-income duration / weighted-average rating | 3.6 years / AA− | 3.4 years / AA− at Sep. 30, 2025 |
The portfolio’s 9M FTE return was (0.3)% versus 6.1% a year earlier. Its fixed-income allocation included $41.594 billion of U.S. government holdings and $23.275 billion of corporate and other debt. Corporate and other debt was about 25% of fixed income, up from 23% at June 30. Asset-backed securities totaled $23.543 billion, including $4.303 billion of CLOs. About $12.0 billion of principal repayments was expected over the next 12 months from fixed-income securities excluding U.S. government securities and short-term investments. Short-term investments and U.S. Treasuries totaled $43.7 billion, just under 45% of portfolio fair value.
Nine-month operating cash flow was $12.5 billion versus $14.4 billion, mainly reflecting $1.2 billion of Florida policyholder credits paid in Q1 2026. Total capital was $42.9 billion versus $37.2 billion at year-end 2025 and $42.3 billion a year earlier. Debt-to-total capital was 19.6%, below the company’s 30% policy limit; estimated consolidated statutory surplus was $35.6 billion. Progressive repurchased 7.7 million shares for $1.6 billion during 9M and paid an $8.0 billion dividend in January. It expects operating cash flow and capital to support obligations, including $500 million of 2.45% notes due January 2027 and $500 million of 2.50% notes due March 2027. The company reported no short-term borrowings.###
Item 3, Quantitative and Qualitative Disclosures About Market Risk
Market risk
| Measure | September 30, 2026 | September 30, 2025 | December 31, 2025 |
|---|---|---|---|
| Interest-rate-sensitive financial-instrument portfolio duration | 3.6 years | 3.4 years | 3.4 years |
| Equity portfolio weighted-average beta | 1.1 | 1.1 | 1.1 |
Progressive reported no material impact relative to the interest-rate and market-risk-sensitive instrument disclosures in its FY2025 Form 10-K.
Item 4, Controls and Procedures
As of period-end, the CEO and CFO concluded that the company’s disclosure controls and procedures were effective. No changes during the most recent fiscal quarter materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
Part II Item 1A, Risk Factors
Risk Factors
The company reported no material changes to the risk factors disclosed in its Form 10-K for the year ended December 31, 2025. Investors should refer to that filing for the company’s existing risk disclosures.
Part II Item 5, Other Information
Rule 10b5-1 Trading Arrangements
During Q3 2026, four executive officers entered into trading arrangements intended to satisfy the affirmative defense under Rule 10b5-1(c). Plans may expire early or be completed under their terms.
| Executive | Position | Date entered | Scheduled expiration | Additional or specified shares |
|---|---|---|---|---|
| Karen B. Bailo | Commercial Lines President | September 22, 2026 | July 30, 2027 | 10 |
| Jonathan S. Bauer | Chief Investment Officer | August 20, 2026 | July 30, 2027 | 475 |
| William L. Clawson II | Chief Human Resources Officer | August 20, 2026 | December 31, 2026 | 5,467 |
| Carl G. Joyce | Vice President and Chief Accounting Officer | August 20, 2026 | February 18, 2027 | 0 |
Where applicable, the arrangements provide for sales of shares issued when specified previously granted equity awards vest, excluding shares withheld for taxes. Some plans also provide for sales and/or gifts of specified amounts of shares already held, potentially including shares from prior award vesting. The filing reports no financial impact from these arrangements.
Shareholder Letter
CEO Susan Patricia Griffith’s quarterly shareholder letter is included as Exhibit 99 to the 10-Q and is available on Progressive’s investor-relations website.